ChemoTech | Mohan Frick, CEO
ChemoTech is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.
Early Detection | Kim Vanderlinden, CEO
Early Detection is focused on detecting cancer at its earliest stages - while the tissue is still considered precancerous.
Siva Therapeutics | Len Pagliaro, CEO
SIVA Therapeutics' mission is to develop minimally invasive devices for cancer treatment.
Endoluxe | Devon Bream, CEO
Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb.
Patheous Health | Michael Peck, CEO
Patheous Integrated Dysphagia Care (iDC) helps seniors and senior care providers diagnose and treat the dysphagia episode of care through the coordinated use of our patented remote patient monitoring technology, mobile imaging diagnostics, evidence-base therapeutic applications and nutrition coaching applications.
Rapid Nexus | Dr. Margaret Kalmeta, CEO & Founder
Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds.
Centese | Randy Preston, Chief Business Officer
Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.
StaplCam | Dinesh Vyas, CEO
World’s first fully disposable, single-incision laparoscopic surgical device with multiple integrated technologies: stapler, grasper and dual-camera with in-line digital display for multiple common surgeries for faster surgery, quick recovery from single small hole and shorter anesthesia.
Moray Medical | Mark Barrish, CEO
Moray Medical is harnessing robotics to democratize edge-to-edge mitral valve repair. The company's initial product is the Coral system, which will combine augmented reality (AR) visualization, a digital user interface, and microfluidics to simplify mitral valve repair procedures.
CorInnova | William Altman, President & CEO
CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure.
Nyra Medical | Murali Padala, CEO & Founder
Nyra Medical is developing an image-guided, catheter-based intervention, called the cardiac leaflet enhancer (CARLEN), for the treatment of mitral and/or tricuspid regurgitation in heart failure patients.
Synova Life Sciences | John Chi, CEO
Synova Life Sciences a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells.
Bone Health Technologies | Laura Yecies, CEO
Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.
Access Vascular | James Biggins, President & CEO
Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.
Strados Labs | Nick Delmonico, President & CEO
User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.
Mindera Health | George Mahaffey, CEO
Mindera's SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.
True Digital Surgery | September Riharb
True Digital Surgery develops next-generation solutions for the operating room. The company's flagship system, Occipta, is a heads-up, digital mircoscope and imaging platform intended to improve surgeons' control and visualization capabilities during reconstructive surgery.
Potrero Medical | Joe Urban, CEO
A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence.
CoapTech | Howard Carolan, CEO
CoapTech has developed a minimally invasive ultrasound for use in creating gastrostomies. The PUMA-G system is FDA-cleared to guide enteral feeding tube placement at the bedside.
Alio | David Kuraguntla, CEO
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.
Miracor Medical | Olivier Delporte, CEO
Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO). A novel first-line therapy used during PCI to positively change the course for Acute MI patients.
Deep Blue Medical Advances | Bill Perry, CEO
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength.
Galen Robotics | Bruce Lichorowic, President & CEO
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
Levita Magnetics | Alberto Rodriguez-Navarro, CEO
Levita Magnetics' innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery.
Carevature | Dennis Farrell, President & CEO
Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions.
restor3d | Ken Gall, CEO
By combining expertise in 3D printing with advanced biomaterials and artificial intelligence, restor3d is creating patient-specific orthopedic implants to reconstruct and repair the human body.
Leonhardt Ventures | Howard Leonhardt, CEO
The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.
Retia Medical | Marc Zemel, CEO
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients.